A phase I trial of arsenic trioxide chemoradiotherapy for infiltrating astrocytomas of childhood
about
Pathology, Molecular Genetics, and Epigenetics of Diffuse Intrinsic Pontine GliomaThe under reporting of recruitment strategies in research with children with life-threatening illnesses: A systematic reviewArsenic Trioxide as a Radiation Sensitizer for 131I-Metaiodobenzylguanidine Therapy: Results of a Phase II Study.KML001, a telomere-targeting drug, sensitizes glioblastoma cells to temozolomide chemotherapy and radiotherapy through DNA damage and apoptosis.The roles of mitoferrin-2 in the process of arsenic trioxide-induced cell damage in human gliomas.Mechanisms regulating glioma invasion.Arsenic trioxide inhibits growth of human chondrosarcoma cells through G2/M arrest and apoptosis as well as autophagy.Cytogenetic landscape of paired neurospheres and traditional monolayer cultures in pediatric malignant brain tumors.MiR-133b contributes to arsenic-induced apoptosis in U251 glioma cells by targeting the hERG channel.The impact of arsenic trioxide and all-trans retinoic acid on p53 R273H-codon mutant glioblastoma.Drug repurposing for glioblastoma based on molecular subtypes.Personalized therapy: CNS HGNET-BCOR responsiveness to arsenic trioxide combined with radiotherapy.Arsenic trioxide-mediated suppression of miR-182-5p is associated with potent anti-oxidant effects through up-regulation of SESN2.Arsenic trioxide inhibits tumor cell growth in malignant rhabdoid tumors in vitro and in vivo by targeting overexpressed Gli1.Arsenic trioxide intravenous infusion combined with transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma with pulmonary metastasis: Long-term outcome analysis.
P2860
Q26801528-7B5DBB10-2975-4F63-999F-00A0BD097F2CQ30847046-BFAFB79D-FE9E-4EBC-986C-0AF157D42E59Q33428982-C39E02E3-81B5-468F-8BD6-48521409B215Q34251033-3311A74D-749A-4710-A52C-CF4BC2F667DCQ34355231-E6244E1C-7AFA-485B-A5DE-8B30C1C09F76Q38386429-0A93B933-4BC9-4B0E-A0D4-424F5136FA2BQ38921254-A2CF3D55-D101-4074-B7B1-A47DA3F65A11Q38925756-01B71B5E-FFC4-4278-B14B-2939C9FA60DBQ38943978-69BC2027-9F40-4BB0-800C-37C98D4332A4Q39036566-F1FFF69B-C1CF-400D-A0CE-C76E6519CA25Q39327459-8C0B15AF-3071-4DEC-9EA4-29B34AA70F48Q49511494-6BBE1565-6C80-41F5-AF6C-56B8E2711CDEQ52584360-2D03A643-398E-4832-8147-E178E44606FEQ53073070-3CD2B3BF-A24A-4B7B-8FA1-11E77EE1E288Q54387722-311830CA-8ADE-45CD-ABB7-97655673C0A5
P2860
A phase I trial of arsenic trioxide chemoradiotherapy for infiltrating astrocytomas of childhood
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
A phase I trial of arsenic tri ...... ting astrocytomas of childhood
@en
type
label
A phase I trial of arsenic tri ...... ting astrocytomas of childhood
@en
prefLabel
A phase I trial of arsenic tri ...... ting astrocytomas of childhood
@en
P2093
P2860
P356
P1433
P1476
A phase I trial of arsenic tri ...... ting astrocytomas of childhood
@en
P2093
Iris C Gibbs
Kenneth J Cohen
Margaret E Macy
Paul G Fisher
Robert J Hayashi
P2860
P304
P356
10.1093/NEUONC/NOT021
P577
2013-03-03T00:00:00Z